Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects.
Okhuysen
Pablo C
PC
Chappell
Cynthia L
CL
Lewis
Dorothy E
DE
Robinson
Prema
P
White
A Clinton
AC
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology; D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000977:Antiparasitic Agents / Q000276:immunology / Q000627:therapeutic use*; D002908:Chronic Disease; D003457:Cryptosporidiosis / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D018664:Interleukin-12 / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D008297:Male; D010865:Pilot Projects; D011897:Random Allocation; D011994:Recombinant Proteins
D000276:Adjuvants, Immunologic; D000977:Antiparasitic Agents; D011994:Recombinant Proteins; D018664:Interleukin-12